Skip to main content
Premium Trial:

Request an Annual Quote

OpGen Raises $3.5M in Bridge Financing

NEW YORK (GenomeWeb News) – Optical mapping technology firm OpGen has raised $3.5 million in bridge financing.

A company spokesman said the funds raised are bridge financing under a Series C round, but he declined to provide additional details. In a document filed with the US Securities and Exchange Commission on Thursday, the Gaithersburg, Md.-based firm said that it is targeting $3.7 million in the round.

According to the filing, the types of securities offered were debt; options, warrants, or other rights to acquire another security; and security to be acquired upon exercise of option, warrant, or other right to acquire security.

In December, OpGen said in an SEC document that it had raised $2.1 million in bridge financing. That amount is part of the $3.5 million noted in yesterday's SEC filing, company officials said.

The company spokesman said two months ago that the $2.1 million would go toward commercialization of OpGen's flagship technology called the Argus Optical Mapping System, launched in the spring of 2010, which uses optical mapping technology for whole-genome sequence assembly and finishing.

Thursday's SEC document did not identify participants in the financing, but said that 27 people had invested in the offering.

OpGen raised $20 million in a Series B financing round a year ago.

The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.